Cholesterol metabolism and resistance to tamoxifen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cholesterol metabolism and resistance to tamoxifen

Published:2012-12 Issue:6 Volume:12 Page:683-689
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Poirot Marc,Silvente-Poirot Sandrine,Weichselbaum Ralph R

Funder

Ludwig Institute for Cancer Research

Institut National de la Santé et de la Recherche Medicale

University of Toulouse III

Institut Claudius Regaud

Fondation de France

Institut National du Cancer

Conseil Régional de Midi-Pyrénées

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference44 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2009

2. Chemoprevention of breast cancer with selective oestrogen-receptor modulators;Jordan;Nat Rev Cancer,2007

3. Four decades of discovery in breast cancer research and treatment – an interview with V. Craig Jordan;Poirot;Int J Dev Biol,2011

4. Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011;Goldhirsch;Ann Oncol,2011

5. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling;Clarke;Oncogene,2003

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing MUC1 to regulate intracellular lipid metabolism: Overcoming sunitinib resistance and inhibiting metastasis in renal cell carcinoma;Chemical Engineering Journal;2024-09

2. Quercetin represses cholesterol metabolism and mitigates resistance to cisplatin in oral squamous cell carcinoma by regulating AGR2/AKT/SREBP2 axis;Heliyon;2024-09

3. MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2;Cell Proliferation;2024-06-26

4. Profiling single cancer cell metabolism via high-content SRS imaging with chemical sparsity;Science Advances;2023-08-18

5. Pathogenic role of 25-hydroxycholesterol in cancer development and progression;Future Oncology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3